column
    Study of Antibacterial Components of Endophytic Streptomyces S009 from Dracaena Cochinchinensis
    SONG Wei, XU Xiaorong, GE Jie, LI Huilin, WEN Aidong, WANG Jingwen, ZHANG Xiaomei, ZHANG Juanli
    2022, 39(20): 2573-2577. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.001
    Abstract PDF
    Study on Anti-fatigue effect of Superfine Powder of Astragali radix Based on the intestinal microecology
    BAI Xuesong, LIU Hea, SONG Yan, LYU Guangfu, LIN He, Lin Zhe, LI Yinqing
    2022, 39(20): 2578-2584. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.002
    Abstract PDF
    Ciprofloxacin Enhances the Inhibitory Effect of Antibody-drug Conjugate(RC48) on the Proliferation of HER2 Positive Tumor Cells
    ZHANG Xinling, WANG Yue, HUANG Changjiang, ZHU M. Marie, LUO Wenting
    2022, 39(20): 2585-2592. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.003
    Abstract PDF
    Effect of Cangfu daotan decoction on ovarian morphology and follicular development in letrozole induced Polycystic Ovary Syndrome model Rats
    WANG Chenye, HUA Zhoujia, YU Jia, DING Caifei
    2022, 39(20): 2593-2599. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.004
    Abstract PDF
    Analysis of the Conclusion of the 2018 National Natural Science Foundation of China in the Field of Pharmacology
    WEI Wei, SUN Xuan, MAO Yunnan, YANG Yanbiao
    2022, 39(20): 2600-2607. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.005
    Abstract PDF
    Study on Fingerprint and Content of Sugar Components in Compound Kushen Injection
    DUAN Xiumei, WANG Pengfei, ZHANG Yameng, BI Xiaofeng, HAI Lina, QIN Wenjie
    2022, 39(20): 2608-2613. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.006
    Abstract PDF
    Establishment of LC Methods for 16 Nucleosides and Nucleotides and the Study of Cleavage Law by Mass Spectrometry
    ZHAO Mingjuan, GU Xiao, ZHENG Jinqi
    2022, 39(20): 2614-2621. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.007
    Abstract PDF
    Metabolomics study of sulidate combined with montelukast sodium in the treatment of bronchial asthma
    WANG Pingping, LI Xiaohui, HE Ye, XIAO Meng
    2022, 39(20): 2622-2626. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.008
    Abstract PDF
    Efficacy and safety of multiple doses of Revefenacin for therapy in patients with moderate to severe chronic obstructive pulmonary disease in stable period: a meta-analysis
    Liu Jiating, LIU Liang, PU Xiaofeng, HE Chengsong, HOU Yi, FENG Xianhu, WANG Guojun
    2022, 39(20): 2627-2636. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.009
    Abstract PDF
    Pharmaceutical Care of a Patient with Drug-induced Pseudomembranous Enteritis
    GU Dongshi, FANG Zhonghong, GU Tongtong, RAN Shan, ZHANG Jun, FANG Huan
    2022, 39(20): 2637-2639. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.010
    Abstract PDF
    Retrospective Analysis of 21 COVID-19 Patients’ Therapeutic Regimen
    HUANG Xiaohong, HUANG Juanjuan, LIN Xiaoyan, LIU Maobai, LIN Li
    2022, 39(20): 2640-2644. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.011
    Abstract PDF
    Research on Innovation Efficiency in Zhejiang Pharmaceutical Industry from the Perspective of Innovation Ecosystem
    ZHENG Jian, HUANG Zhixiang, QIAN Wenwen, XU Xiangcai, SHEN Lixin
    2022, 39(20): 2645-2651. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.012
    Abstract PDF
    Establishment of Index System of Accessibility to Drugs for Chronic Diseases Based on Delphi Method
    CHEN Tongdan, GAO Qilong, REN Jinwen, HUA Shibin, ZHU Jiaying
    2022, 39(20): 2652-2657. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.013
    Abstract PDF
    Application Progress of New Technology for Innovative Design and Quality Control of Tablets
    XU Shijun, WANG Xuecheng, WU Zhenfeng, LI Yuanhui, LIU Zhenfeng, LUO Xiaorong, ZHOU Tonghui, YANG Ming
    2022, 39(20): 2658-2668. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.014
    Abstract PDF
    Research Progress of STAT3 Targeted Small Molecule Inhibitors in the Treatment of Hepatocellular Carcinoma
    FU Honghong, HUANG Haiming, LIN Wen, ZHAO Feng, YANG Linjie, LYU Liang
    2022, 39(20): 2669-2676. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.015
    Abstract PDF
    Research Progress of Bioactive Constituents and Quality Standard of Gecko
    AN Fengxia, TANG Jian, MENG Xiangsong, LI Yanling, SU Ting, LU Baowei
    2022, 39(20): 2677-2683. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.016
    Abstract PDF
    Advance of PEGylated Metal-orgaric Framworks Drug Delivery Systems
    ZHU Rongyue, CAI Mengru, YAO Yu, YIN Dongge, WANG Kaixin, HU Xueling, FU Tingting, HUANG Huating, LIAO Shilang, YIN Xingbin, NI Jian
    2022, 39(20): 2684-2690. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.017
    Abstract PDF
    Research Status on Safety of Long-term Application of Azithromycin for Non-antibacterial Purposes
    MENG Fanyan, LIANG Hongyi, JI Bo
    2022, 39(20): 2691-2696. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.018
    Abstract PDF
    Research Progress of Selective PARP-1 Inhibitors
    WU Dan, HUO Xiaoli, ZHU Huajian, SHAO Jia'an, HOU Wei, ZHANG Jiankang
    2022, 39(20): 2697-2706. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.019
    Abstract PDF
    Expert Consensus on Technical Practice for the in Vitro Release Test of Topical Semisolid Dosage Forms for Skin and Mucous Membrane Preparations
    The Transdermal Drug Delivery Committee of the World Federation of Chinese Medicine Societies
    2022, 39(20): 2707-2716. DOI: 10.13748/j.cnki.issn1007-7693.2022.20.020
    Abstract PDF